LUPUS ERYTHEMATOSUS, SYSTEMIC
Clinical trials for LUPUS ERYTHEMATOSUS, SYSTEMIC explained in plain language.
Never miss a new study
Get alerted when new LUPUS ERYTHEMATOSUS, SYSTEMIC trials appear
Sign up with your email to follow new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat lupus
Disease control Not yet recruitingThis trial tests a one-time treatment called CAR-T cell therapy for people with systemic lupus erythematosus (lupus) that hasn't improved with standard medications. The therapy uses a patient's own immune cells, which are modified in a lab to find and destroy the B cells that dri…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE1, PHASE2 • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug cevostamab enters early human testing for lupus
Disease control Not yet recruitingThis early-stage trial will test the safety and tolerability of a new drug, cevostamab, in 46 people with systemic lupus erythematosus, some of whom also have active lupus nephritis. The drug is given intravenously, and researchers will monitor side effects and how the drug moves…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can fish oil fight lupus inflammation? new study aims to find out
Disease control Not yet recruitingThis study tests whether taking high-dose omega-3 (fish oil) pills for 12 weeks can reduce inflammation and cell damage in women with lupus who are in remission. Researchers will measure changes in blood markers and telomere length, which is linked to aging. The goal is to see if…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug firsekibart aims to tame lupus flares in Hard-to-Treat patients
Disease control Not yet recruitingThis pilot study tests Firsekibart, a biologic that blocks IL-1, in 15 adults with mild to moderate lupus who still have symptoms despite standard therapy. Participants receive three shots over 8 weeks, then stop the drug to see if symptoms return. The goal is to see if this appr…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE4 • Sponsor: Chinese SLE Treatment And Research Group • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can an online program help young people with lupus and dermatomyositis feel less stressed?
Symptom relief Not yet recruitingThis study tests a new online program called TEAM-LEADS designed to help teens and young adults (ages 13-22) with lupus or dermatomyositis reduce stress and improve heart-healthy behaviors like diet, exercise, and sleep. The program is self-guided and completed online. The study …
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Hypnosis may replace pills for Needle-Phobic kids
Symptom relief Not yet recruitingThis study tests whether hypnotherapy can reduce pain and anxiety in children aged 6 to 18 during needle procedures like injections or blood draws. About 70 kids with conditions like juvenile arthritis or lupus will be randomly assigned to receive either hypnotherapy or standard …
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: Aarhus University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC